Debiopharm Group and Mercury Therapeutics Sign Development and Commercialization of Debio 0930

News   Aug 10, 2009

 
Debiopharm Group and Mercury Therapeutics Sign Development and Commercialization of Debio 0930
 
 
 

RELATED ARTICLES

Recognizing Ice Before it’s Ice

News

A new study used infrared and raman spectroscopy to reveal how the antifreeze proteins that protect insects in the cold work.

READ MORE

Modified Form of Botox Could Replace Opioids as Treatment for Chronic Pain

News

A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.

READ MORE

Synthetic Material That Detects Enzymatic Activity

News

Scientists integrate protein and polymer building blocks to create stimulus-responsive systems

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy